Keryx Biopharmaceuticals
Latest round
- Series B
Last raised
- Dec 1999
Total raised
- Undisclosed
Investors
- 1
About Keryx Biopharmaceuticals
Keryx Biopharmaceuticals develops therapies for chronic kidney disease. The company was founded as an independent entity and is headquartered in New York, US.Keryx Biopharmaceuticals is committed to developing and commercializing innovative treatments for patients with chronic kidney disease (CKD). Its primary focus is on FDA-approved products that address the complications associated with CKD, ultimately aiming to improve patient quality of life.64 mn. The company plans to focus on the development of new therapies and potential market entries into international regions by 2025. These initiatives are part of Keryx's strategy to improve patient outcomes and expand its reach in the chronic kidney disease sector.
Who invested in Keryx Biopharmaceuticals
1 investor across 1 round
See all investors in Keryx Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 1, 1999
Amount
Undisclosed
Investors
Questions about Keryx Biopharmaceuticals
Who invested in Keryx Biopharmaceuticals?
Keryx Biopharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Keryx Biopharmaceuticals raised?
Keryx Biopharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Keryx Biopharmaceuticals last raise money?
Keryx Biopharmaceuticals's most recent round on record is a Series B, in Dec 1999.
What does Keryx Biopharmaceuticals do?
Keryx Biopharmaceuticals develops therapies for chronic kidney disease.
Where is Keryx Biopharmaceuticals headquartered?
Keryx Biopharmaceuticals is headquartered in New York, US.
Which VCs invest in companies like Keryx Biopharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Keryx Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Keryx Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.